BDSX

7.5608.92%
HM

Hany Massarany

Independent Director

Mr. Hany Massarany has served as a Director of Accelerate Diagnostics, Inc. since May 20, 2020 and Board Chairman since February 22, 2023. Mr. Massarany was the Chief Executive Officer of GenMark Diagnostics, Inc. from May 1, 2011 until February 10, 2020. He serves as an Independent Director of Accelerate Diagnostics, Inc. since May 20, 2021 and is its Independent Chairman of the Board since February 22, 2023. He serves as Independent Director of Biodesix, Inc. since July 2020. Mr. Massarany was the President of GenMark Diagnostics, Inc. from May 2011 until February 10, 2020. Mr. Massarany served as the Chief Operating Officer of Ventana Medical Systems Inc. since July 2007 until February 2008 and served as its Executive Vice President of Worldwide Operations since July 2006 until July 2007, served as its Senior Vice President of Corporate Strategy and Development, served as its Senior Vice President of Global Operations, served as its Vice President and General Manager of North American Commercial Operations since 1999. Throughout his tenure at Ventana, Mr. Massarany held a number of global leadership positions and was instrumental in establishing its business operations and growth in more than 43 countries worldwide. Prior to joining Ventana, Mr. Massarany held various executive management positions in Asia Pacific and the United States for leading medical technology companies including Bayer Diagnostics, Chiron Diagnostics Corp. and Australian Diagnostics Corp. He served as Head of Roche Tissue Diagnostics, the diagnostics division of a leading healthcare company F. Hoffman-La Roche Limited since February 2008. Mr. Massarany is a Trustee of the Massarany Family Trust. From February 2009 to April 2011, Mr. Massarany served as President of Ventana Medical Systems. He was the Director of GenMark Diagnostics, Inc. from May 1, 2011 until February 10, 2020. He served as a Non-Executive Director of Lumos Diagnostics Holdings Limited from 27 July 2020 to 22 March 2021. He holds a B.S. in Microbiology and Immunology from Monash University in Australia and an M.B.A. from the University of Melbourne.

Positions